Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN3 | Q9H6Z9 | 4/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 5/20 | 0.41 |
| ▸ | VEGFA | P15692 | 2/20 | 0.41 |
| ▸ | FLT1 | P17948 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PPID | Q08752 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3760876 | 0.89 | EGLN3 (0.54) | EGLN3EGLN1VEGFAFLT1ALDH1A1 | |
| SCHEMBL3754317 | 0.88 | EGLN3 (0.55) | EGLN3EGLN1VEGFAFLT1 | |
| SCHEMBL3758199 | 0.83 | EGLN3 (0.39) | EGLN3EGLN1VEGFAFLT1MAPT | |
| SCHEMBL3396710 | 0.75 | EGLN3 (0.71) | EGLN3EGLN1VEGFAFLT1 | |
| SCHEMBL3518821 | 0.74 | EGLN3 (0.49) | EGLN3MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3766318 | 0.74 | MAPT (0.39) | EGLN3EGLN1VEGFAFLT1MAPT | |
| SCHEMBL3396187 | 0.74 | EGLN3 (0.76) | EGLN3EGLN1VEGFAFLT1 | |
| SCHEMBL3524259 | 0.72 | EGLN3 (0.52) | EGLN3MAPTPOLBNPC1RAB9A | |
| SCHEMBL3762383 | 0.72 | EGLN3 (0.57) | EGLN3EGLN1VEGFAFLT1MAPT | |
| SCHEMBL3761040 | 0.72 | HPGD (0.45) | EGLN3MAPTTP53NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305154-A1 | Prolyl Hydroxylase Inhibitors | GLAXOSMITHKLINE LLC | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305154-A1 | Prolyl Hydroxylase Inhibitors | HIF1AN, EGLN3, EGLN2 | EGLN3 2/4885EGLN1 6/4885VEGFA 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.